Cargando…

The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats

BACKGROUND: Endothelial dysfunction is a crucial early phenomenon in vascular diseases linked to diabetes mellitus and associated to enhanced oxidative stress. There is increasing evidence about the role for pro-inflammatory cytokines, like interleukin-1β (IL-1β), in developing diabetic vasculopathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallejo, Susana, Palacios, Erika, Romacho, Tania, Villalobos, Laura, Peiró, Concepción, Sánchez-Ferrer, Carlos F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276125/ https://www.ncbi.nlm.nih.gov/pubmed/25518980 http://dx.doi.org/10.1186/s12933-014-0158-z

Ejemplares similares

Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
por: Romacho, Tania, et al.
Publicado: (2013)

Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
por: Peiró, Concepción, et al.
Publicado: (2016)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013)

Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity
por: Vallejo, Susana, et al.
Publicado: (2011)

Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
por: Romacho, Tania, et al.
Publicado: (2020)

Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010)

The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016)

Role of glutathione biosynthesis in endothelial dysfunction and fibrosis
por: Espinosa-Díez, Cristina, et al.
Publicado: (2017)

Erratum to: Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
por: Peiró, Concepción, et al.
Publicado: (2017)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

The angiotensin‐(1‐7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation
por: Romero, Alejandra, et al.
Publicado: (2019)

Mechanisms Involved in the Aging-Induced Vascular Dysfunction
por: El Assar, Mariam, et al.
Publicado: (2012)

Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
por: Maier, André, et al.
Publicado: (2015)

Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo
por: Azcutia, Verónica, et al.
Publicado: (2010)

Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
por: Franzetti, Marco, et al.
Publicado: (2020)

The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis
por: Somagutta, Manoj Kumar Reddy, et al.
Publicado: (2021)

Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction
por: Romero, Alejandra, et al.
Publicado: (2022)

Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats
por: Serizawa, Ken-ichi, et al.
Publicado: (2011)

Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra
por: Terrada, Celine, et al.
Publicado: (2011)

Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
por: Yamanaka, Gaku, et al.
Publicado: (2021)

The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice
por: Ku, Eu Jeong, et al.
Publicado: (2022)

Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants
por: Green, Elys A., et al.
Publicado: (2022)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats
por: Strunz, Célia MC, et al.
Publicado: (2011)

IL‐1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis
por: Gorelik, M., et al.
Publicado: (2019)

Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
por: Mulders-Manders, Catharina M., et al.
Publicado: (2017)

High-cholesterol diet enriched with onion affects endothelium-dependent relaxation and NADPH oxidase activity in mesenteric microvessels from Wistar rats
por: González-Peña, Diana, et al.
Publicado: (2014)

Protocatechualdehyde restores endothelial dysfunction in streptozotocin-induced diabetic rats
por: Ji, Bin, et al.
Publicado: (2021)

Diacylglycerol kinase ζ inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus
por: Bilim, Olga, et al.
Publicado: (2008)

The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes
por: Marangoni, Maria N, et al.
Publicado: (2014)

In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats
por: Savi, Monia, et al.
Publicado: (2017)

Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
por: Kain, Vasundhara, et al.
Publicado: (2011)

Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats
por: Ho, Yi-Jin, et al.
Publicado: (2014)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor – anakinra
por: Divithotawela, Chandima, et al.
Publicado: (2015)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
por: Hübner, Max, et al.
Publicado: (2020)

Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI)
por: Yu, Xichun, et al.
Publicado: (2007)

Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in Streptozotocin-induced diabetic rats
por: Ho, Yi-Jin, et al.
Publicado: (2013)

Anakinra, an interleukin-1 receptor antagonist, increases the morphine analgesic effect and decreases morphine tolerance development by modulating oxidative stress and endoplasmic reticulum stress in rats
por: AVCI, Onur, et al.
Publicado: (2020)

Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
por: Odegaard, Andrew O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0f0uqrbirfqtbuef61g7pga1je